Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Slade

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
JAMA|September 11, 2024
Chimeric Transplant VillanelleMichael J Slade
JAMA Oncology|August 3, 2023
CyclesMichael J Slade
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2024
EpistemeMichael J Slade
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2026
Erratum: Indistinguishable From MagicMichael J Slade
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2026
Indistinguishable From MagicMichael J Slade
Best Practice & Research. Clinical Haematology|December 6, 2020
CD123 bi-specific antibodies in development in AML: What do we know so far?Michael J Slade, Geoffrey L Uy
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2026
A Call for Compassion: How You Can Help Get Multiple Myeloma Added to the Social Security Administration's Compassionate Allowances ListAkshay Mehta, Matthew Kaczynski, Sarah Addison, et al.
Annals of Hematology|September 3, 2024
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myelomaScott R Goldsmith, Michael J Slade, Mark Fiala, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 22, 2025
Convenience Versus Continuity: A Pilot Study of Care Transfer to a Satellite Clinic for Patients With Plasma Cell DyscrasiasAngela M Vickroy, Margaret Kavanaugh, Jordan Smith, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2023
Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and DexamethasoneAlexa J Loncharich, Mark A Fiala, Michael J Slade, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
JAMA|September 11, 2024
Chimeric Transplant VillanelleMichael J Slade
JAMA Oncology|August 3, 2023
CyclesMichael J Slade
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2024
EpistemeMichael J Slade
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2026
Erratum: Indistinguishable From MagicMichael J Slade
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2026
Indistinguishable From MagicMichael J Slade
Best Practice & Research. Clinical Haematology|December 6, 2020
CD123 bi-specific antibodies in development in AML: What do we know so far?Michael J Slade, Geoffrey L Uy
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2026
A Call for Compassion: How You Can Help Get Multiple Myeloma Added to the Social Security Administration's Compassionate Allowances ListAkshay Mehta, Matthew Kaczynski, Sarah Addison, et al.
Annals of Hematology|September 3, 2024
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myelomaScott R Goldsmith, Michael J Slade, Mark Fiala, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 22, 2025
Convenience Versus Continuity: A Pilot Study of Care Transfer to a Satellite Clinic for Patients With Plasma Cell DyscrasiasAngela M Vickroy, Margaret Kavanaugh, Jordan Smith, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2023
Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and DexamethasoneAlexa J Loncharich, Mark A Fiala, Michael J Slade, et al.
Pageof 2